Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas

Published:2013-10-18 Issue:1 Volume:116 Page:83-88
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Wang Fei,Gao Hua,Li Chuzhong,Bai Jiwei,Lu Runchun,Cao Lei,Wu Yongtu,Hong Lichuan,Wu Yonggang,Lan Xiaolei,Zhang Yazhuo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-013-1276-2.pdf

Reference20 articles.

1. Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485–534. doi: 10.1210/er.2005-9998

2. Iyer P, Molitch ME (2011) Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas. Endocr Pract 17:e55–e58. doi: 10.4158/EP10369.CR

3. Molitch ME (2005) Pharmacologic resistance in prolactinoma patients. Pituitary 8:43–52. doi: 10.1007/s11102-005-5085-2

4. Oh MC, Aghi MK (2011) Dopamine agonist-resistant prolactinomas. J Neurosurg 114:1369–1379. doi: 10.3171/2010.11.jns101369

5. Wu ZB, Zheng WM, Su ZP, Chen Y, Wu JS, Wang CD, Lin C, Zeng YJ, Zhuge QC (2010) Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior. J Neurooncol 99:25–32. doi: 10.1007/s11060-009-0107-y

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of RP1L1 gene in disease;Gene;2024-06

2. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma;Frontiers in Endocrinology;2023-12-13

3. Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?;Endocrine Oncology;2022-05-01

4. Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma;Cancers;2021-10-26

5. Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond;Expert Review of Endocrinology & Metabolism;2019-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3